Infections and transplantation go hand in hand and is a major limiting factor in the transplantation programs. Though a lot of advancement has happened in this field, the evidence is still scarce, not oriented to the Indian subcontinent and difficult to be implemented in resource limited settings. To address these issues the Midterm ISOT 2026 has a program curated to understanding, solving the everyday infectious problems faced by the transplantation community.
Highlights of common problems that will be addressed
- Screening for TB in recipient and donor-
- Should I do it
- How do I do it
- Its positive, what do I do
- This guy has active TB, when shall I plan transplant
- What medicines I should use
- Will this medicine cause graft dysfunction
- Fungal infections
- Is it a fungal infection
- How do I confirm
- Should I initiate treatment pending reports
- How long should I continue treatment
- Is tissue diagnosis a must
- PUO
- Oh not again- is this viral, bacterial, fungal or not infectious at all
- Finance is limited- what all tests should I send
- Should I go all in with treatment or a simple antibiotic
- Does this UTI require surgical intervention
- Immunosuppression
- What is the infection risk of this patient
- Which Induction shall I use
- How do I balance immunosuppression and risk of infection
- Is this drug better than the other
- Evaluation
- This person has already received antibiotic, should I send culture or not
- Culture is negative, what do I do
- This new test has given so many positives, what should I do
- How can I get a fast report
- This person can’t afford all tests, what do I do
- Management
- Is this sepsis- should I use a sepsis filter?
- Counts are already low- should I give CMV prophylaxis
- No clear guidelines, how shall I treat BKV
- Isn’t this dose a little high for my patient?
- Others
- What all tests are mandatory for this deceased donor
- Should I accept this donor or reject?
- My patient is already 78 yrs, how shall I treat?
